COMBINED ANTIALLERGIC DRUG FOR NASAL APPLICATION Russian patent published in 2021 - IPC A61K9/08 A61K31/135 A61K31/137 A61K31/495 A61P27/14 A61P37/08 

Abstract RU 2744097 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to a combined antiallergic drug for nasal application for treating acute rhinitis, allergic rhinitis, vasomotor rhinitis, chronic rhinitis, sinusitis, as an auxiliary method for otitis treatment, in preparation for nasal surgeries, for elimination of mucous membrane edema of nasal cavity and paranasal sinuses after surgical interventions in this area, comprising phenylephrine or a pharmaceutically acceptable salt thereof and cetirizine or a pharmaceutically acceptable salt thereof, as well as a pharmaceutically acceptable solvent, a humectant, a preserving agent, a buffer, a complexing agent, characterized by that the ratio of phenylephrine or phenylephrine hydrochloride and cetirizine or cetirizine hydrochloride is 1:1 with the following content of components, wt %: phenylephrine or phenylephrine hydrochloride 0.05–1.05; cetirizine or cetirizine hydrochloride 0.05–1.05; humidifier 0.0015–8.5; preserving agent 0.005–0.3; buffer 0.02–1.1; complexing agent 0.005–0.1; solvent—balance, and also relates to a combined antiallergic drug for nasal application for treating acute rhinitis, allergic rhinitis, vasomotor rhinitis, chronic rhinitis, sinusitis, as an auxiliary method for otitis treatment, in preparation for nasal surgeries, for eliminating edema of the nasal mucosa and paranasal sinuses after surgical interventions in this region, containing phenylephrine or phenylephrine hydrochloride and cetirizine or cetirizine hydrochloride, as well as a pharmaceutically acceptable humectant, a preserving agent, a buffer, complexing agent, characterized by that the ratio of phenylephrine or phenylephrine hydrochloride and cetirizine or cetirizine hydrochloride is 1:1 with the following components in 1 ml of the drug, mg: phenylephrine or phenylephrine hydrochloride 0.5–10.5; cetirizine or cetirizine hydrochloride 0.5–10.5; humidifier 0.015–85.0; preservative 0.05–3.0; pharmaceutically acceptable buffer 0.2–11; complexing agent 0.05–1.0; solvent is the rest.

EFFECT: group of inventions provides high therapeutic effect (anti-inflammatory, anti-edema, antihistaminic) and increased storage life, and also provides a risk of side effects and complications.

5 cl, 1 tbl

Similar patents RU2744097C2

Title Year Author Number
METHOD FOR PREPARING AQUEOUS PHARMACEUTICAL COMPOSITION INCLUDING HYDROXYMETHYLPROPYLMETHYLCELLULOSE, AND PHARMACEUTICAL COMPOSITIONS PREPARED BY SAID METHOD 2006
  • Popov Todor Aleksandrov
  • Tzachev Kristo Tzachev
RU2389476C2
COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS 2013
  • Ignar Diane Michele
  • Levin Daren Scott
RU2652352C2
NASAL PHARMACEUTICAL COMPOSITIONS AND METHODS OF APPLICATION THEREOF 2004
  • Chaudri Imitjaz
RU2380090C2
HOMEOPATHIC PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE AND EXAMINATION OF CHRONIC INFLAMMATORY DISEASES OF THE UPPER AND LOWER RESPIRATORY TRACT ON THE BASIS OF NATURAL COMPONENTS OF PLANT, ANIMAL AND MINERAL ORIGIN AND ITS USE 2022
  • Nersesyan Marina Vladislavovna
RU2798661C1
STABLE PHARMACEUTICAL COMPOSITION WITH FIXED DOSE, CONTAINING MOMETASONE AND OLOPATADINE 2014
  • Dkhuppad Ulkhas
  • Katkurvar Ashok
  • Gupta Yashvant
  • Ankam Radzhesh
  • Dkhatrak Chandrakant
RU2687551C2
COMPOSITIONS AND METHODS OF TREATING PARANASAL SINUS AND PARASITIC NASAL MUCOSA DISEASES WITH NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS 2017
  • Solis Herrera, Arturo
RU2718061C1
NEW COMBINATION OF ANTI-HISTAMINE AGENTS HAVING NO SEDATIVE ACTION WITH COMPOUNDS EFFECTING TO LEUKOTRIEN ACTION FOR RHINITIS/CONJUNCTIVITIS TREATMENT 2001
  • Kuss Khil'Degard
  • Ehngel' Jurgen
  • Shelenyj Ishtvan
RU2292208C2
NOVEL PHARMACEUTIC COMPOSITION AND ITS APPLICATION IN METHOD OF TREATMENT OF PATIENTS WITH HYPERAEMIA AND EDEMA OF MUCOUS MEMBRANE OF UPPER AIRWAYS 2005
  • Atkinson Khartli Kehmpbell
RU2423979C2
PHARMACEUTICAL COMPOSITION OF N,N'-BIS[2-(1H-IMIDAZOL-4-YL)ETHYL]MALONAMIDE 2022
  • Nebolsin Vladimir Evgenevich
RU2818073C2
COMPOSITION FOR TREATING RHINITIS AND RELATED DISEASES AND METHOD FOR PREPARING IT 2006
  • Peresvetoff-Morat Lena
  • Karlsson Anders
  • B'Erke Torb'Em
RU2444351C2

RU 2 744 097 C2

Authors

Kopatko Svetlana Aleksandrovna

Dates

2021-03-02Published

2018-02-28Filed